For many types of cancer, immunotherapy, a type of biologic therapy, has been a game changer. Why? Precision medicine is at the heart of immunotherapy, currently one of the hottest areas of cancer research. Immunotherapy harnesses the power of our immune systems to identify and control diseases...
As previously published inNatureand presented at the Society for Immunotherapy of Cancer (SITC) 2022 last November, the technology was further developed by PACT Pharma, using CRISPR gene editing to insert genes into immune cells to efficiently redirect them to recognize mutations in ...
First-line therapy for advanced/metastatic non-small-cell lung cancer Checkpoint pathways in NSCLC Immunotherapy for NSCLC—proof of principle Moving to first-line: PD-(L)1 inhibitors as monotherapy and PD-L1 as a biomarker First-line combinations: PD-(L)1 inhibitors with platinum-based chemother...
The 5-year survival rate is > 85% but this rapidly decreases to <10% for late diagnosis of metastasized cancer [164]. Consequently, patient prognosis and treatment options highly depend on the stage of the disease. gFOBT is based on blood detection in feces and despite its high specificity...
Radically new immunotherapy approaches have been proposed, which target the immune system, rather than the cancer itself. Promising preliminary results on subsets of patients have led to a surge in research and clinical trials investigating the potential for combining new immunomodulatory agents with ...
Takuji Okusaka,Makoto Ueno,Tosiya Sato,Yuji Heike.Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine ...
Your doctor may suggest you take any of the targeted therapy drugs now approved by the FDA for metastatic breast cancer along with chemotherapy. Immunotherapy This may be a part of treatment if you have these types of cancer cells: Triple-negative ...
studies expressed a desire for basic information about their diagnosis, they also exhibited diversity in their motivations for seeking cancer information; the emotions experienced; and the nature, quantity, and sources of the sought information, along with the strategies used to manage this information...
Cancer has a knack for deceiving the immune system, giving itself time to grow and spread. Now, researchers at QIMR Berghofer Medical Research Institute have identified one way it does so, and found a method to counter it in mouse tests.
After you're diagnosed with non-small-cell lung cancer (NSCLC) that has spread (metastatic), you'll likely get treatments like chemotherapy, radiation, targeted therapy, and immunotherapy. They may help you live longer and lessen symptoms so you feel better. ...